Los Angeles' new vaccine mandate goes into effect Monday, requiring proof of vaccination to enter most public indoor spaces, including: any establishments where food or beverages are served; gyms and fitness venues; entertainment and recreation venues; personal care establishments; and buildings owned or operated by the city.
Patrons shop indoors at the Hollywood & Highland shopping center in Hollywood, Calif., March 19, 2021.
Aaronp/bauer-griffin/GC Images
The mandate also requires proof of vaccination for large outdoor events with 5,000 or more attendees.
Enforcement will begin on Nov. 29.
-ABC News' Catherine Thorbecke
Nov 08, 2021, 11:16 AM EST
Regeneron monoclonal antibody lowers COVID risk by nearly 82%, company says
Regeneron's monoclonal antibody treatment can lower the risk of contracting COVID-19 by nearly 82% for up to eight months, the company said.
Regeneron's monoclonal antibody treatment, given as an intravenous infusion or a subcutaneous injection, is already FDA-authorized as a way to prevent COVID-19 among people who have recently been exposed and are considered "high risk" for more serious illness. This new data shows that when given as preventative measure, it dramatically reduces the risk of infection for up to eight months.
A box and vial of the Regeneron monoclonal antibody is seen at a COVID-19 treatment site opened by Florida Governor Ron DeSantis at Camping World Stadium in Orlando, Fla., Aug. 19, 2021.
SOPA Images/LightRocket via Getty Images, FILE
Regeneron and the FDA say that vaccination is the best way to prevent infection and serious illness. However, Regeneron's antibody treatment can be a good option for people who are immune compromised or haven't mounted an adequate immune response through the vaccine.
A group of tourists who crossed the Rainbow bridge by foot enter the U.S. from Canada, as the U.S. reopens air and land borders to fully vaccinated travellers for the first time since coronavirus disease (COVID-19) restrictions were imposed, in Niagara Falls, N.Y., Nov. 8, 2021.
Lindsay Dedario/Reuters
Performers engage with travelers as they queue to check into Virgin Atlantic and Delta Air Lines flights at Heathrow Airport Terminal 3, following the lifting of restrictions on the entry of non-U.S. citizens to the U.S., in London, Nov. 8, 2021.
Henry Nicholls/Reuters
In January, as the vaccine was distributed on both sides of the Atlantic, the ban was kept in place, with the Biden administration stating concerns about the delta variant.
On Oct. 20, the Biden administration announced it was lifting the ban on vaccinated travelers.
The ban, which only applies to vaccinated travelers, still excludes many countries where the vaccine is not yet easily available or recognized by the U.S.
People queue to check into Virgin Atlantic and Delta Air Lines flights at Heathrow Airport Terminal 3, following the lifting of restrictions on the entry of non-U.S. citizens to the U.S., in London, Nov. 8, 2021.
Henry Nicholls/Reuters
-ABC News' Zoe Chevalier
Nov 08, 2021, 8:04 AM EST
Global COVID-19 cases top 250 million in under 2 years
The worldwide number of people who have been diagnosed with COVID-19 surpassed 250 million on Monday, according to a count kept by Johns Hopkins University.
The United States, India and Brazil account for about a third of the recorded cases, Johns Hopkins data shows.
A health care worker provides medical assistance to a COVID-19 patient inside the intensive care unit at a hospital that treats patients infected with the novel coronavirus in Kiev, Ukraine, on Nov. 1, 2021. One of Europe's poorest countries, Ukraine has been hit by a huge rise in COVID-19 infections with the more contagious delta variant.
Sergei Supinsky/AFP via Getty Images, File
The grim milestone came as some countries in Eastern Europe, including Russia, Ukraine and Greece, grapple with record levels of newly reported cases.
The pandemic began less than two years ago after the virus was first detected in Wuhan, China, in December 2019.
